The global autism spectrum disorder treatment market was valued at $27,272.7 million in 2021, and is projected to reach $43,166.16 million by 2031, registering a CAGR of 4.6% from 2022 to 2031.
A class of sophisticated neurological illnesses known as autism spectrum disorder (ASD) is characterized by a wide range of behavioral patterns and difficulties with social interaction and communication. Compulsive behavior, incorrect social interaction, a learning handicap, anxiety, sensitivity to hearing, repetitive motions, and many other characteristics are among the key indications and symptoms of ASD.
The increase in prevalence of autism spectrum disorder and rise in demand for early diagnosis of autism spectrum disorders boost the growth of market. For instance, in November 2021, as per the study of Ben-Gurion University researchers and colleagues, it was found that, autism spectrum disorder diagnosis by 2.5 years of age leads to dramatic improvements in social symptoms as compared to those diagnosed later in life. Thus, rise in awareness about autism spectrum disorder and rise in demand for early diagnosis of autism spectrum disorder drive the growth of market.
Moreover, the increase in prevalence of autism spectrum disorder and rise in awareness regarding service of autism spectrum disorder are the key factors that drive the growth of autism spectrum disorder treatment market. For instance, in March 2022, as per the report of World Health Organization (WHO), it was estimated that worldwide about one in 100 children has autism spectrum disorder.
Furthermore, the increase in awareness about autism spectrum disorder and rise in contribution of government & non-government organizations to provide autism spectrum disorder diagnosis & service propel the growth of market. For instance, ASERT (Autism Services, Education, Resources and Training) is an organization of medical centers, and universities, announced the launch of Autism Awareness, Community Education and Support (AACES), a program designed to increase independence and decrease isolation among young people with autism spectrum disorder (ASD).
Moreover, the increase in R&D activities for development of advanced autism spectrum disorder treatment, advancements in diagnosis of disease, rise in U.S. food and drug administration (USFDA) approvals, and novel product launch in market by key players boost the market growth. For instance, in October 2021, Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological disorders and diseases, received clearance from the U.S. Food and Drug Administration (FDA) of its investigational new drug (IND) application for lead candidate, AB-2004, a gut-targeted, molecular therapeutic for the service of irritability associated with autism spectrum disorder. Furthermore, advancements in autism spectrum disorder treatments such as online training platforms and mobile diseases for autism spectrum further contribute in market growth. However, the high cost of autism spectrum disorder treatment and lack of awareness about disease may hinder the growth of market.
The Autism spectrum disorder treatment market is segmented on the basis of service, disease, location and region. By service , the market is classified into behavioral approaches, early intervention, medication, and others.
Depending on disease, the market is classified into autistic disorder, asperger's syndrome, and pervasive development disorder (PDD).
The major companies profiled in the report include Abbvie Inc, Axial therapeutics, The Bristol Myers Squibb Company, Cognoa Inc, Curemark LLC, Dfusion Inc, EarliTec Diagnostics Inc, Jaguar Gene Therapy, Jazz Pharmaceuticals, Johnson & Johnson, Neurim Pharmaceuticals Ltd., Novartis AG, PaxMedica Inc, Pfizer Inc, Stalicla SA, Teva Pharmaceutical Industries Ltd. and Yamo Pharmaceuticals LLC.
A class of sophisticated neurological illnesses known as autism spectrum disorder (ASD) is characterized by a wide range of behavioral patterns and difficulties with social interaction and communication. Compulsive behavior, incorrect social interaction, a learning handicap, anxiety, sensitivity to hearing, repetitive motions, and many other characteristics are among the key indications and symptoms of ASD.
The increase in prevalence of autism spectrum disorder and rise in demand for early diagnosis of autism spectrum disorders boost the growth of market. For instance, in November 2021, as per the study of Ben-Gurion University researchers and colleagues, it was found that, autism spectrum disorder diagnosis by 2.5 years of age leads to dramatic improvements in social symptoms as compared to those diagnosed later in life. Thus, rise in awareness about autism spectrum disorder and rise in demand for early diagnosis of autism spectrum disorder drive the growth of market.
Moreover, the increase in prevalence of autism spectrum disorder and rise in awareness regarding service of autism spectrum disorder are the key factors that drive the growth of autism spectrum disorder treatment market. For instance, in March 2022, as per the report of World Health Organization (WHO), it was estimated that worldwide about one in 100 children has autism spectrum disorder.
Furthermore, the increase in awareness about autism spectrum disorder and rise in contribution of government & non-government organizations to provide autism spectrum disorder diagnosis & service propel the growth of market. For instance, ASERT (Autism Services, Education, Resources and Training) is an organization of medical centers, and universities, announced the launch of Autism Awareness, Community Education and Support (AACES), a program designed to increase independence and decrease isolation among young people with autism spectrum disorder (ASD).
Moreover, the increase in R&D activities for development of advanced autism spectrum disorder treatment, advancements in diagnosis of disease, rise in U.S. food and drug administration (USFDA) approvals, and novel product launch in market by key players boost the market growth. For instance, in October 2021, Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological disorders and diseases, received clearance from the U.S. Food and Drug Administration (FDA) of its investigational new drug (IND) application for lead candidate, AB-2004, a gut-targeted, molecular therapeutic for the service of irritability associated with autism spectrum disorder. Furthermore, advancements in autism spectrum disorder treatments such as online training platforms and mobile diseases for autism spectrum further contribute in market growth. However, the high cost of autism spectrum disorder treatment and lack of awareness about disease may hinder the growth of market.
The Autism spectrum disorder treatment market is segmented on the basis of service, disease, location and region. By service , the market is classified into behavioral approaches, early intervention, medication, and others.
Depending on disease, the market is classified into autistic disorder, asperger's syndrome, and pervasive development disorder (PDD).
By location, market is categorized into hospital, education counsellor center, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Abbvie Inc, Axial therapeutics, The Bristol Myers Squibb Company, Cognoa Inc, Curemark LLC, Dfusion Inc, EarliTec Diagnostics Inc, Jaguar Gene Therapy, Jazz Pharmaceuticals, Johnson & Johnson, Neurim Pharmaceuticals Ltd., Novartis AG, PaxMedica Inc, Pfizer Inc, Stalicla SA, Teva Pharmaceutical Industries Ltd. and Yamo Pharmaceuticals LLC.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the autism spectrum disorders market analysis from 2021 to 2031 to identify the prevailing autism spectrum disorders market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the autism spectrum disorders market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global autism spectrum disorders market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Disease
- Autistic Disorder
- Asperger Syndrome
- Pervasive development disorder (PDD)
- Other
By Service
- Behavioural Approaches
- Gender
- Male
- Female
- Early Intervention
- Gender
- Male
- Female
- Medication
- Gender
- Male
- Female
- Other Services
- Gender
- Male
- Female
By Location
- Hospitals
- Education Counsellor Center
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Abbvie Inc
- Axial therapeutics
- Bristol Myers Squibb Co.
- Cognoa Inc
- Curemark LLC
- dfusion inc.
- EarliTec Diagnostics Inc
- Jazz Pharmaceuticals
- Johnson & Johnson
- Novartis AG
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: AUTISM SPECTRUM DISORDERS MARKET, BY DISEASE
4.1 Overview
4.1.1 Market size and forecast
4.2 Autistic Disorder
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Asperger Syndrome
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Pervasive development disorder (PDD)
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Other
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: AUTISM SPECTRUM DISORDERS MARKET, BY SERVICE
5.1 Overview
5.1.1 Market size and forecast
5.2 Behavioural Approaches
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Behavioural Approaches Autism Spectrum Disorders Market by Gender
5.2.4.1 Male Market size and forecast, by region
5.2.4.2 Female Market size and forecast, by region
5.3 Early Intervention
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.3.4 Early Intervention Autism Spectrum Disorders Market by Gender
5.3.4.1 Male Market size and forecast, by region
5.3.4.2 Female Market size and forecast, by region
5.4 Medication
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.4.4 Medication Autism Spectrum Disorders Market by Gender
5.4.4.1 Male Market size and forecast, by region
5.4.4.2 Female Market size and forecast, by region
5.5 Other Services
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.5.4 Other Services Autism Spectrum Disorders Market by Gender
5.5.4.1 Male Market size and forecast, by region
5.5.4.2 Female Market size and forecast, by region
CHAPTER 6: AUTISM SPECTRUM DISORDERS MARKET, BY LOCATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Education Counsellor Center
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: AUTISM SPECTRUM DISORDERS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Disease
7.2.3 North America Market size and forecast, by Service
7.2.3.1 North America Behavioural Approaches Autism Spectrum Disorders Market by Gender
7.2.3.2 North America Early Intervention Autism Spectrum Disorders Market by Gender
7.2.3.3 North America Medication Autism Spectrum Disorders Market by Gender
7.2.3.4 North America Other Services Autism Spectrum Disorders Market by Gender
7.2.4 North America Market size and forecast, by Location
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Disease
7.2.5.1.2 Market size and forecast, by Service
7.2.5.1.3 Market size and forecast, by Location
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Disease
7.2.5.2.2 Market size and forecast, by Service
7.2.5.2.3 Market size and forecast, by Location
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Disease
7.2.5.3.2 Market size and forecast, by Service
7.2.5.3.3 Market size and forecast, by Location
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Disease
7.3.3 Europe Market size and forecast, by Service
7.3.3.1 Europe Behavioural Approaches Autism Spectrum Disorders Market by Gender
7.3.3.2 Europe Early Intervention Autism Spectrum Disorders Market by Gender
7.3.3.3 Europe Medication Autism Spectrum Disorders Market by Gender
7.3.3.4 Europe Other Services Autism Spectrum Disorders Market by Gender
7.3.4 Europe Market size and forecast, by Location
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Disease
7.3.5.1.2 Market size and forecast, by Service
7.3.5.1.3 Market size and forecast, by Location
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Disease
7.3.5.2.2 Market size and forecast, by Service
7.3.5.2.3 Market size and forecast, by Location
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Disease
7.3.5.3.2 Market size and forecast, by Service
7.3.5.3.3 Market size and forecast, by Location
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Disease
7.3.5.4.2 Market size and forecast, by Service
7.3.5.4.3 Market size and forecast, by Location
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Disease
7.3.5.5.2 Market size and forecast, by Service
7.3.5.5.3 Market size and forecast, by Location
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Disease
7.3.5.6.2 Market size and forecast, by Service
7.3.5.6.3 Market size and forecast, by Location
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Disease
7.4.3 Asia-Pacific Market size and forecast, by Service
7.4.3.1 Asia-Pacific Behavioural Approaches Autism Spectrum Disorders Market by Gender
7.4.3.2 Asia-Pacific Early Intervention Autism Spectrum Disorders Market by Gender
7.4.3.3 Asia-Pacific Medication Autism Spectrum Disorders Market by Gender
7.4.3.4 Asia-Pacific Other Services Autism Spectrum Disorders Market by Gender
7.4.4 Asia-Pacific Market size and forecast, by Location
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Disease
7.4.5.1.2 Market size and forecast, by Service
7.4.5.1.3 Market size and forecast, by Location
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Disease
7.4.5.2.2 Market size and forecast, by Service
7.4.5.2.3 Market size and forecast, by Location
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Disease
7.4.5.3.2 Market size and forecast, by Service
7.4.5.3.3 Market size and forecast, by Location
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Disease
7.4.5.4.2 Market size and forecast, by Service
7.4.5.4.3 Market size and forecast, by Location
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Disease
7.4.5.5.2 Market size and forecast, by Service
7.4.5.5.3 Market size and forecast, by Location
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Disease
7.5.3 LAMEA Market size and forecast, by Service
7.5.3.1 LAMEA Behavioural Approaches Autism Spectrum Disorders Market by Gender
7.5.3.2 LAMEA Early Intervention Autism Spectrum Disorders Market by Gender
7.5.3.3 LAMEA Medication Autism Spectrum Disorders Market by Gender
7.5.3.4 LAMEA Other Services Autism Spectrum Disorders Market by Gender
7.5.4 LAMEA Market size and forecast, by Location
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Disease
7.5.5.1.2 Market size and forecast, by Service
7.5.5.1.3 Market size and forecast, by Location
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Disease
7.5.5.2.2 Market size and forecast, by Service
7.5.5.2.3 Market size and forecast, by Location
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Disease
7.5.5.3.2 Market size and forecast, by Service
7.5.5.3.3 Market size and forecast, by Location
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Disease
7.5.5.4.2 Market size and forecast, by Service
7.5.5.4.3 Market size and forecast, by Location
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Abbvie Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Axial therapeutics
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Bristol Myers Squibb Co.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Cognoa Inc
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Curemark LLC
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 dfusion inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 EarliTec Diagnostics Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Jazz Pharmaceuticals
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Johnson & Johnson
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Novartis AG
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
List of Tables
Table 1. Global Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 2. Autism Spectrum Disorders Market Size, for Autistic Disorder, by Region, 2021-2031 ($Million)
Table 3. Autism Spectrum Disorders Market for Autistic Disorder, by Country, 2021-2031 ($Million)
Table 4. Autism Spectrum Disorders Market Size, for Asperger Syndrome, by Region, 2021-2031 ($Million)
Table 5. Autism Spectrum Disorders Market for Asperger Syndrome, by Country, 2021-2031 ($Million)
Table 6. Autism Spectrum Disorders Market Size, for Pervasive Development Disorder (Pdd), by Region, 2021-2031 ($Million)
Table 7. Autism Spectrum Disorders Market for Pervasive Development Disorder (Pdd), by Country, 2021-2031 ($Million)
Table 8. Autism Spectrum Disorders Market Size, for Other, by Region, 2021-2031 ($Million)
Table 9. Autism Spectrum Disorders Market for Other, by Country, 2021-2031 ($Million)
Table 10. Global Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 11. Autism Spectrum Disorders Market Size, for Behavioural Approaches, by Region, 2021-2031 ($Million)
Table 12. Autism Spectrum Disorders Market for Behavioural Approaches, by Country, 2021-2031 ($Million)
Table 13. Global Behavioural Approaches Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 14. Autism Spectrum Disorders Market, for Male, by Region, 2021-2031 ($Million)
Table 15. Autism Spectrum Disorders Market, for Female, by Region, 2021-2031 ($Million)
Table 16. Autism Spectrum Disorders Market Size, for Early Intervention, by Region, 2021-2031 ($Million)
Table 17. Autism Spectrum Disorders Market for Early Intervention, by Country, 2021-2031 ($Million)
Table 18. Global Early Intervention Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 19. Autism Spectrum Disorders Market, for Male, by Region, 2021-2031 ($Million)
Table 20. Autism Spectrum Disorders Market, for Female, by Region, 2021-2031 ($Million)
Table 21. Autism Spectrum Disorders Market Size, for Medication, by Region, 2021-2031 ($Million)
Table 22. Autism Spectrum Disorders Market for Medication, by Country, 2021-2031 ($Million)
Table 23. Global Medication Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 24. Autism Spectrum Disorders Market, for Male, by Region, 2021-2031 ($Million)
Table 25. Autism Spectrum Disorders Market, for Female, by Region, 2021-2031 ($Million)
Table 26. Autism Spectrum Disorders Market Size, for Other Services, by Region, 2021-2031 ($Million)
Table 27. Autism Spectrum Disorders Market for Other Services, by Country, 2021-2031 ($Million)
Table 28. Global Other Services Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 29. Autism Spectrum Disorders Market, for Male, by Region, 2021-2031 ($Million)
Table 30. Autism Spectrum Disorders Market, for Female, by Region, 2021-2031 ($Million)
Table 31. Global Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 32. Autism Spectrum Disorders Market Size, for Hospitals, by Region, 2021-2031 ($Million)
Table 33. Autism Spectrum Disorders Market for Hospitals, by Country, 2021-2031 ($Million)
Table 34. Autism Spectrum Disorders Market Size, for Education Counsellor Center, by Region, 2021-2031 ($Million)
Table 35. Autism Spectrum Disorders Market for Education Counsellor Center, by Country, 2021-2031 ($Million)
Table 36. Autism Spectrum Disorders Market Size, for Others, by Region, 2021-2031 ($Million)
Table 37. Autism Spectrum Disorders Market for Others, by Country, 2021-2031 ($Million)
Table 38. Autism Spectrum Disorders Market, by Region, 2021-2031 ($Million)
Table 39. North America Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 40. North America Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 41. North America Behavioural Approaches Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 42. North America Early Intervention Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 43. North America Medication Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 44. North America Other Services Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 45. North America Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 46. North America Autism Spectrum Disorders Market, by Country, 2021-2031 ($Million)
Table 47. U.S. Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 48. U.S. Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 49. U.S. Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 50. Canada Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 51. Canada Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 52. Canada Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 53. Mexico Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 54. Mexico Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 55. Mexico Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 56. Europe Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 57. Europe Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 58. Europe Behavioural Approaches Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 59. Europe Early Intervention Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 60. Europe Medication Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 61. Europe Other Services Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 62. Europe Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 63. Europe Autism Spectrum Disorders Market, by Country, 2021-2031 ($Million)
Table 64. Germany Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 65. Germany Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 66. Germany Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 67. France Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 68. France Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 69. France Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 70. UK Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 71. UK Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 72. UK Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 73. Italy Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 74. Italy Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 75. Italy Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 76. Spain Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 77. Spain Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 78. Spain Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 79. Rest of Europe Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 80. Rest of Europe Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 81. Rest of Europe Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 82. Asia-Pacific Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 83. Asia-Pacific Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 84. Asia-Pacific Behavioural Approaches Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 85. Asia-Pacific Early Intervention Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 86. Asia-Pacific Medication Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 87. Asia-Pacific Other Services Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 88. Asia-Pacific Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 89. Asia-Pacific Autism Spectrum Disorders Market, by Country, 2021-2031 ($Million)
Table 90. Japan Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 91. Japan Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 92. Japan Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 93. China Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 94. China Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 95. China Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 96. Australia Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 97. Australia Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 98. Australia Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 99. India Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 100. India Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 101. India Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 102. Rest of Asia-Pacific Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 103. Rest of Asia-Pacific Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 104. Rest of Asia-Pacific Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 105. LAMEA Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 106. LAMEA Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 107. LAMEA Behavioural Approaches Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 108. LAMEA Early Intervention Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 109. LAMEA Medication Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 110. LAMEA Other Services Autism Spectrum Disorders Market, by Gender, 2021-2031 ($Million)
Table 111. LAMEA Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 112. LAMEA Autism Spectrum Disorders Market, by Country, 2021-2031 ($Million)
Table 113. Brazil Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 114. Brazil Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 115. Brazil Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 116. Saudi Arabia Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 117. Saudi Arabia Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 118. Saudi Arabia Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 119. South Africa Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 120. South Africa Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 121. South Africa Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 122. Rest of LAMEA Autism Spectrum Disorders Market, by Disease, 2021-2031 ($Million)
Table 123. Rest of LAMEA Autism Spectrum Disorders Market, by Service, 2021-2031 ($Million)
Table 124. Rest of LAMEA Autism Spectrum Disorders Market, by Location, 2021-2031 ($Million)
Table 125. Abbvie Inc.: Company Snapshot
Table 126. Abbvie Inc.: Operating Segments
Table 127. Abbvie Inc.: Product Portfolio
Table 128. Abbvie Inc.: Net Sales
Table 129. Abbvie Inc.: Key Strategies
Table 130. Axial Therapeutics: Company Snapshot
Table 131. Axial Therapeutics: Operating Segments
Table 132. Axial Therapeutics: Product Portfolio
Table 133. Axial Therapeutics: Net Sales
Table 134. Axial Therapeutics: Key Strategies
Table 135. Bristol Myers Squibb Co.: Company Snapshot
Table 136. Bristol Myers Squibb Co.: Operating Segments
Table 137. Bristol Myers Squibb Co.: Product Portfolio
Table 138. Bristol Myers Squibb Co.: Net Sales
Table 139. Bristol Myers Squibb Co.: Key Strategies
Table 140. Cognoa Inc.: Company Snapshot
Table 141. Cognoa Inc.: Operating Segments
Table 142. Cognoa Inc.: Product Portfolio
Table 143. Cognoa Inc.: Net Sales
Table 144. Cognoa Inc.: Key Strategies
Table 145. Curemark LLC: Company Snapshot
Table 146. Curemark LLC: Operating Segments
Table 147. Curemark LLC: Product Portfolio
Table 148. Curemark LLC: Net Sales
Table 149. Curemark LLC: Key Strategies
Table 150. Dfusion Inc.: Company Snapshot
Table 151. Dfusion Inc.: Operating Segments
Table 152. Dfusion Inc.: Product Portfolio
Table 153. Dfusion Inc.: Net Sales
Table 154. Dfusion Inc.: Key Strategies
Table 155. Earlitec Diagnostics Inc.: Company Snapshot
Table 156. Earlitec Diagnostics Inc.: Operating Segments
Table 157. Earlitec Diagnostics Inc.: Product Portfolio
Table 158. Earlitec Diagnostics Inc.: Net Sales
Table 159. Earlitec Diagnostics Inc.: Key Strategies
Table 160. Jazz Pharmaceuticals: Company Snapshot
Table 161. Jazz Pharmaceuticals: Operating Segments
Table 162. Jazz Pharmaceuticals: Product Portfolio
Table 163. Jazz Pharmaceuticals: Net Sales
Table 164. Jazz Pharmaceuticals: Key Strategies
Table 165. Johnson & Johnson: Company Snapshot
Table 166. Johnson & Johnson: Operating Segments
Table 167. Johnson & Johnson: Product Portfolio
Table 168. Johnson & Johnson: Net Sales
Table 169. Johnson & Johnson: Key Strategies
Table 170. Novartis AG: Company Snapshot
Table 171. Novartis AG: Operating Segments
Table 172. Novartis AG: Product Portfolio
Table 173. Novartis AG: Net Sales
Table 174. Novartis AG: Key Strategies
List of Figures
Figure 1. Autism Spectrum Disorders Market Segmentation
Figure 2. Autism Spectrum Disorders Market, 2021-2031
Figure 3. Autism Spectrum Disorders Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Autism Spectrum Disorders Mark.:Drivers, Restraints and Opportunities
Figure 12. Autism Spectrum Disorders Market, By Disease, 2021(%)
Figure 13. Comparative Share Analysis of Autistic Disorder Autism Spectrum Disorders Market, 2021-2031(%)
Figure 14. Comparative Share Analysis of Asperger Syndrome Autism Spectrum Disorders Market, 2021-2031(%)
Figure 15. Comparative Share Analysis of Pervasive Development Disorder (Pdd) Autism Spectrum Disorders Market, 2021-2031(%)
Figure 16. Comparative Share Analysis of Other Autism Spectrum Disorders Market, 2021-2031(%)
Figure 17. Autism Spectrum Disorders Market, By Service, 2021(%)
Figure 18. Comparative Share Analysis of Behavioural Approaches Autism Spectrum Disorders Market, 2021-2031(%)
Figure 19. Comparative Share Analysis of Early Intervention Autism Spectrum Disorders Market, 2021-2031(%)
Figure 20. Comparative Share Analysis of Medication Autism Spectrum Disorders Market, 2021-2031(%)
Figure 21. Comparative Share Analysis of Other Services Autism Spectrum Disorders Market, 2021-2031(%)
Figure 22. Autism Spectrum Disorders Market, By Location, 2021(%)
Figure 23. Comparative Share Analysis of Hospitals Autism Spectrum Disorders Market, 2021-2031(%)
Figure 24. Comparative Share Analysis of Education Counsellor Center Autism Spectrum Disorders Market, 2021-2031(%)
Figure 25. Comparative Share Analysis of Others Autism Spectrum Disorders Market, 2021-2031(%)
Figure 26. Autism Spectrum Disorders Market by Region, 2021
Figure 27. U.S. Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 28. Canada Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 29. Mexico Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 30. Germany Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 31. France Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 32. Uk Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 33. Italy Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 34. Spain Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 35. Rest of Europe Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 36. Japan Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 37. China Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 38. Australia Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 39. India Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 40. Rest of Asia-Pacific Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 41. Brazil Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 42. Saudi Arabia Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 43. South Africa Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 44. Rest of LAMEA Autism Spectrum Disorders Market, 2021-2031($Million)
Figure 45. Top Winning Strategies, by Year
Figure 46. Top Winning Strategies, by Development
Figure 47. Top Winning Strategies, by Company
Figure 48. Product Mapping of Top 10 Players
Figure 49. Competitive Dashboard
Figure 50. Competitive Heatmap of Top 10 Key Players
Figure 51. Abbvie In.: Net Sales, ($Million)
Figure 52. Axial Therapeutic.: Net Sales, ($Million)
Figure 53. Bristol Myers Squibb Co.: Net Sales, ($Million)
Figure 54. Cognoa In.: Net Sales, ($Million)
Figure 55. Curemark LL.: Net Sales, ($Million)
Figure 56. Dfusion Inc.: Net Sales, ($Million)
Figure 57. Earlitec Diagnostics In.: Net Sales, ($Million)
Figure 58. Jazz Pharmaceutical.: Net Sales, ($Million)
Figure 59. Johnson & Johnso.: Net Sales, ($Million)
Figure 60. Novartis A.: Net Sales, ($Million)
Executive Summary
According to the report, “Autism Spectrum Disorders Market," the autism spectrum disorders market was valued at $27.3 billion in 2021, and is estimated to reach $43.2 billion by 2031, growing at a CAGR of 4.6% from 2022 to 2031.Autism spectrum disorder is a neurodevelopment disorder or disability. The exact cause of autism spectrum disease is unknown however, common and rare inherited genetic variations along with non-inherited traits are the common causes of autism spectrum disorder. A patient who suffers from this disorder faces difficulties in social interaction, communication, daily activities, and non-verbal interactions. Patients with autism spectrum disorder show high dependency on repetitive routines and they are very sensitive to environmental changes. However, children show symptoms at an early age as 12 months of age, and symptoms change with their age. This disorder remains a lifetime however early detection helps to improve symptoms. Early diagnosis of this disorder is important during the developmental period of a child.
A surge in cases of autism spectrum disorder, rise in demand for early diagnosis, increase in number of birth rates, a surge in a number of autism spectrum disorder treatment centers, and rise in awareness regarding service of this disorder are the key factors that drive the growth of Autism Spectrum Disorders Market Size.
The increase in the prevalence of autism spectrum disorder and rise in awareness about autism spectrum disorder drives the growth of the Autism Spectrum Disorders Market Size. For instance, in 2021, according to The Autism and Developmental Disabilities Monitoring (ADDM) Network, a program funded by the Centers for Disease Control and Prevention (CDC), an estimate is that about 1 in 44, 8-year-old children have been identified with ASD. In addition, an increase in awareness about autism spectrum disorders and a rise in demand for early diagnosis of various autism spectrum disorders such as autistic disorder, Asperger's syndrome, and pervasive development disorder (PDD) contribute to the growth of the Autism Spectrum Disorders Industry.
Furthermore, the rise in the birth rate, an increase in autism spectrum disorder s diagnosis rate, private & government funding to develop healthcare infrastructure, and a rise in R&D activities for autism spectrum disorder s service boosts the growth of the Autism Spectrum Disorders Industry. For instance, in February 2021, EarliTec Diagnostics, a digital health company, engaged in developing novel diagnostic and therapeutic products for children with autism spectrum disorder s (ASD) and early childhood vulnerabilities, raised $19.5 million in financing to support the early diagnosis and service of autism spectrum disorder (ASD) in children.
Furthermore, Autism Spectrum Disorders Market Trends that drive the growth of the Autism Spectrum Disorders Market Forecast include increase in service approvals, a rise in clinical trials for autism spectrum disorders (ASD), and a new product launched in the market. For instance, in December 2021, Jaguar Gene Therapy, a company accelerating breakthroughs in gene therapy for sizeable patient populations suffering from severe genetic diseases, today announced additional details, including target genes, for its initial preclinical pipeline programs: JAG101 for Type 1 galactosemia; JAG201 for a genetic cause of autism spectrum disorder (ASD) and Phelan-McDermid syndrome and other severe neurodevelopmental disorders with a SHANK3 mutation or deletion; and JAG301 for Type 1 diabetes. Furthermore, the rise in healthcare expenditure and improvements in healthcare facilities in developing nations contributes to the growth of the autism spectrum disorder treatment market.
The Autism spectrum disorder treatment market is segmented into service, and disease. location and region.
On the basis of service, the market is divided into behavioral approaches, early intervention, medication, and others. The behavioral approaches segment dominated the Autism Spectrum Disorders Market Share in 2021, and this trend is expected to continue during the forecast period, owing to increasing adoption of behavioral approaches for treatment and an increase in awareness about autism spectrum diseases (ASD) treatment.
By disease, the market is categorized into autistic disorder, Asperger's syndrome, pervasive development disorder (PDD), and others. The autistic disorder segment has the largest Autism Spectrum Disorders Market Share in 2021, and this trend is expected to continue during the forecast period, owing to the increase in the prevalence of the autistic disorder.
By location, the market is classified into hospital, education counselor centers, and others. The education counselor center segment has the largest market share in 2021, and this trend is expected to continue during the forecast period, owing to growth in the prevalence of autism spectrum diseases and a rise in healthcare expenditures.
North America accounted for a majority of the global autism spectrum disorder treatment market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to rising in the prevalence of autism spectrum disorder (ASD), well-established healthcare infrastructure, and the presence of key players in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to an increase in incidences of premature childbirth, growing awareness about autism spectrum disorder (ASD), and a high population base.
Key Findings of the Study
- On the basis of service, the behavioral approaches segment was the highest contributor to the Autism Spectrum Disorders Market Analysis in 2021.
- Based on disease, the autistic disorder segment was the highest contributor to the market in 2021.
- Depending on location, the education counselor center segment was the highest contributor to the market in 2021.
- Region-wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
Companies Mentioned
- Abbvie Inc
- Axial therapeutics
- Bristol Myers Squibb Co.
- Cognoa Inc
- Curemark LLC
- dfusion inc.
- EarliTec Diagnostics Inc
- Jazz Pharmaceuticals
- Johnson & Johnson
- Novartis AG
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 300 |
| Published | September 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 27272.7 million |
| Forecasted Market Value ( USD | $ 43166.16 million |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
